SB-277,011-A

SB2770112DACS.svg

SB-277,011-A is a chemical compound that acts as a potent and selective antagonist for the dopamine receptor D3 (D3 receptor). It has been widely used in scientific research to investigate the role of D3 receptors in various physiological and pathological processes.

Chemical Properties

SB-277,011-A has the chemical formula C18H19Cl2N3O and a molecular weight of 364.27 g/mol. It is characterized by its high affinity and selectivity for the D3 receptor over other dopamine receptor subtypes, such as dopamine receptor D2 (D2 receptor).

Pharmacology

As a D3 receptor antagonist, SB-277,011-A binds to the D3 receptor and inhibits its activity. This action has been shown to modulate several neurological and psychiatric conditions, including schizophrenia, addiction, and Parkinson's disease. The compound has been instrumental in elucidating the role of D3 receptors in these disorders.

Research Applications

SB-277,011-A has been used extensively in preclinical studies to explore the therapeutic potential of D3 receptor antagonists. It has demonstrated efficacy in animal models of drug addiction, where it reduces drug-seeking behavior and relapse. Additionally, it has been studied for its potential benefits in treating cognitive deficits associated with schizophrenia and other neuropsychiatric disorders.

Safety and Toxicology

The safety profile of SB-277,011-A has been evaluated in various studies. While it is generally well-tolerated in animal models, further research is needed to fully understand its long-term effects and potential toxicity in humans.

See Also

• Dopamine receptor
• Dopamine receptor D2
• Schizophrenia
• Addiction
• Parkinson's disease

External Links

-

   This article is a medical stub. You can help WikiMD by expanding it!